Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Donor”

673 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 673 results

Not applicableStudy completedNCT03140462
What this trial is testing

Influence of Genetic Polymorphism of Donor on Tacrolimus Concentration in Liver Transplant

Who this might be right for
Liver Transplantation
National Taiwan University Hospital 96
Early research (Phase 1)UnknownNCT03591302
What this trial is testing

Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs.

Who this might be right for
Immune Tolerance
Stephan Busque 25
Not applicableLooking for participantsNCT00001846
What this trial is testing

Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use

Who this might be right for
Blood DonorsResearch SubjectsApheresis
National Institutes of Health Clinical Center (CC) 5,000
Testing effectiveness (Phase 2)Study completedNCT00262886
What this trial is testing

Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Rochester 35
Not applicableStudy completedNCT02990559
What this trial is testing

Neuroimaging of Donor Iron Deficient Study

Who this might be right for
Iron Deficiency
Columbia University 75
Not applicableStudy completedNCT02944851
What this trial is testing

Comparison of the Accuracy of Non-invasive Hemoglobin Measurement (SpHb) and Vena Cava Inferior Ultrasound

Who this might be right for
Blood Donors, Traumatic Blood Loss
Haseki Training and Research Hospital 128
Early research (Phase 1)Study completedNCT00255710
What this trial is testing

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Testing effectiveness (Phase 2)Study completedNCT02581007
What this trial is testing

Reduced Intensity Conditioning Transplant Using Haploidentical Donors

Who this might be right for
Chronic Myelogenous LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndrome+7 more
Northside Hospital, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT00003116
What this trial is testing

High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Case Comprehensive Cancer Center 66
Post-approval studies (Phase 4)Study completedNCT03781726
What this trial is testing

Multi-center Study to Transplant Hepatitis-C Infected Kidneys

Who this might be right for
Renal Failure ChronicHepatitis C
Raymond Chung 30
Not applicableStudy completedNCT00900406
What this trial is testing

Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Vanderbilt-Ingram Cancer Center 190
Not applicableStudy completedNCT01901458
What this trial is testing

Two Different Collection Sets for Peripheral Blood Progenitor Cell Apheresis With Spectra Optia®

Who this might be right for
Healthy Allogeneic DonorsGranulocyte Colony-stimulating Factor (G-CSF) Mobilized
Heinrich-Heine University, Duesseldorf 50
Testing effectiveness (Phase 2)Study completedNCT01818284
What this trial is testing

Plerixafor for Stem Cell Mobilization in Normal Donors

Who this might be right for
Blood And Marrow Transplantation
M.D. Anderson Cancer Center 22
Not applicableStudy completedNCT03366441
What this trial is testing

Reactivation of Inactive Blood Donors

Who this might be right for
Blood Donor
Guangzhou Blood Center 11,880
Not applicableStudy completedNCT00772083
What this trial is testing

Caring for Those Who Share: Improving the Health of Wisconsin Blood Donors

Who this might be right for
AnemiaColorectal Cancer
Medical College of Wisconsin 400
Testing effectiveness (Phase 2)Study completedNCT00789776
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+13 more
Fred Hutchinson Cancer Center 41
Testing effectiveness (Phase 2)UnknownNCT00061568
What this trial is testing

Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias

Who this might be right for
Congenital Hemolytic AnemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 130
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Testing effectiveness (Phase 2)Study completedNCT00691015
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Barbara Ann Karmanos Cancer Institute 48
Not applicableStudy completedNCT01233921
What this trial is testing

Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+86 more
Martin, Paul 6
Load More Results